Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Multiple Myeloma × Methotrexate × Clear all

Phase

Status

Sponsor Class

OTHER 25 NIH 1 NETWORK 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Arthritis, Rheumatoid 8 Leukemia 5 Graft vs Host Disease 5 Lymphoma, Follicular 4 Leukemia, Myeloid, Acute 4 Breast Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Myelodysplastic Syndromes 3 Lymphoma 3 Psoriasis 2 Neoplasms 2 Leukemia, Myeloid, Chronic-Phase 2 Leukemia, Myeloid, Accelerated Phase 2 Hematologic Neoplasms 2 Head and Neck Neoplasms 2 Carcinoma, Squamous Cell 2 Burkitt Lymphoma 2 Urinary Bladder Neoplasms 1 Stomatitis 1 Recurrence 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Osteosarcoma 1 Neutropenia 1 Mycosis Fungoides 1 Multiple Myeloma 1 Meningeal Neoplasms 1 Meningeal Carcinomatosis 1 Lymphoproliferative Disorders 1 Lymphoma, T-Cell, Cutaneous 1

Interventions

Dexamethasone 241 Bortezomib 135 Lenalidomide 108 pomalidomide 84 daratumumab 77 carfilzomib 56 Cyclophosphamide 33 Calcium Dobesilate 31 belantamab mafodotin 26 fludarabine 23 elotuzumab 22 Melphalan 21 isatuximab 19 ixazomib 18 Prednisone 15 venetoclax 14 selinexor 14 talquetamab 13 Panobinostat 12 plerixafor 11 Granulocyte Colony-Stimulating Factor 11 idecabtagene vicleucel 10 Zoledronic Acid 10 Thalidomide 10 Injections 9 pembrolizumab 8 iberdomide 8 Methylprednisolone 8 Azacitidine 8 siltuximab 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04960579 2026-03-13

MM

Poseida Therapeutics, Inc.

Phase 1 Recruiting

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡